×
BrightSpring Health Services Net Profit Margin 2022-2025 | BTSG
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
BrightSpring Health Services net profit margin from 2022 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
BrightSpring Health Services Net Profit Margin 2022-2025 | BTSG
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
BrightSpring Health Services net profit margin from 2022 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$138.3B
CVS Health (CVS)
$80.7B
Elevance Health (ELV)
$77.8B
Cencora (COR)
$57.7B
DiDi Global (DIDIY)
$28.9B
Labcorp Holdings (LH)
$20.6B
Natera (NTRA)
$20.3B
BioMerieux (BMXMF)
$16.9B
EUROFINS SCIENT (ERFSF)
$13.9B
CochLear (CHEOY)
$12.8B
Solventum (SOLV)
$12.6B
ICON (ICLR)
$11.6B
Revvity (RVTY)
$11.2B
Viatris (VTRS)
$10.7B
Medpace Holdings (MEDP)
$9B
Sonic Healthcare (SKHHY)
$8.8B
Avantor (AVTR)
$8.8B
HealthEquity (HQY)
$8.4B
Caris Life Sciences,�Inc (CAI)
$8B
Charles River Laboratories (CRL)
$7.6B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$4.9B
Sotera Health (SHC)
$3.2B
Surgery Partners (SGRY)
$2.9B
Alignment Healthcare (ALHC)
$2.6B
Concentras Parent (CON)
$2.5B
Organon (OGN)
$2.5B
GeneDx Holdings (WGS)
$2.3B
Progyny (PGNY)
$2B
PACS (PACS)
$1.9B